Drug Shortage Report for XYLOCAINE 2%
Report ID | 218682 |
Drug Identification Number | 02302438 |
Brand name | XYLOCAINE 2% |
Common or Proper name | lidocaine HCI 2% Plain 10x20mL MD Vial |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION BLOCK/INFILTRATION |
Packaging size | 10 vials |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-24 |
Estimated end date | 2024-02-26 |
Actual end date | 2024-02-26 |
Shortage status | Resolved |
Updated date | 2024-02-27 |
Company comments | VR44567CA1 XYLOCAINE 20MG/ML MDV 10X20ML VIAL CA AS |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-02-06 | English | Compare |
v2 | 2024-02-06 | French | Compare |
v3 | 2024-02-20 | English | Compare |
v4 | 2024-02-20 | French | Compare |
v5 | 2024-02-27 | English | Compare |
v6 | 2024-02-27 | French | Compare |
Showing 1 to 6 of 6